Gland Pharma and Go Digit GI among 12 midcap stocks that may lose midcap status soon

Nuvama Alternative Research estimates that the large-cap cut-off will rise to around Rs 99,200 crore, up from Rs 84,000 crore in June 2024, while the mid-cap threshold is projected to reach approximately Rs 32,400 crore, compared to Rs 27,500 crore in June 2024.